000			02125 a2200517 4500
005			20250514064254.0
264		0	_c20030430
008			200304s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2003.06.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aBannerji, Rajat
245	0	0	_aApoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cApr 2003
300			_a1466-71 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCD55 Antigens _xmetabolism
650	0	4	_aCD59 Antigens _xmetabolism
650	0	4	_aComplement System Proteins _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFlow Cytometry
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aImmunoblotting
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _ximmunology
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aMyeloid Cell Leukemia Sequence 1 Protein
650	0	4	_aNeoplasm Proteins _xmetabolism
650	0	4	_aProto-Oncogene Proteins _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aRituximab
650	0	4	_aTreatment Outcome
650	0	4	_abcl-2-Associated X Protein
700	1		_aKitada, Shinichi
700	1		_aFlinn, Ian W
700	1		_aPearson, Michael
700	1		_aYoung, Donn
700	1		_aReed, John C
700	1		_aByrd, John C
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 21 _gno. 8 _gp. 1466-71
856	4	0	_uhttps://doi.org/10.1200/JCO.2003.06.012 _zAvailable from publisher's website
999			_c12489548 _d12489548